Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04796-z
PubMed Identifier: 33109240
Publication URI: http://europepmc.org/abstract/MED/33109240
Type: Journal Article/Review
Volume: 21
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215